Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Imig

Showing results (21-30 of 193) with videos related to

Pageof 20
Sort By:
American Journal of Physiology. Renal Physiology|March 11, 2016
Renal blood flow autoregulation: what are the contributions for nitric oxide or superoxide to modulate the myogenic response?John D Imig
Frontiers in Physiology|August 29, 2022
Frontiers in metabolic physiology grand challengesJohn D Imig
Cardiovascular Drug Reviews|September 12, 2006
Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitorsJohn D Imig
Clinical Science (London, England : 1979)|March 29, 2022
SARS-CoV-2 spike protein causes cardiovascular disease independent of viral infectionJohn D Imig
Kidney360|December 18, 2025
NF Erythroid 2-Related Factor 2 Peroxisome Proliferator-Activated Receptor-γ Crosstalk: Reprogramming Monocytic Myeloid-Derived Suppressor Cells in Kidney DiseaseJohn D Imig
Frontiers in Pharmacology|October 19, 2020
Editorial: Clinical Paths for Soluble Epoxide Hydrolase InhibitorsJohn D Imig, Christophe Morisseau
Physiological Reports|October 26, 2013
Afferent Arteriolar Responses to β,γ-methylene ATP and 20-HETE are not Blocked by ENaC InhibitionTasuku Nagasawa, John D Imig
Comprehensive Physiology|May 31, 2013
Immune and inflammatory role in renal diseaseJohn D Imig, Michael J Ryan
American Journal of Physiology. Renal Physiology|September 11, 2015
Reply to "Letter to the editor: 'Concern regarding quantification of urinary nephrin by commercially available ELISA'"Jennifer C Sullivan, John D Imig
American Journal of Hypertension|March 19, 2011
Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndromeAbdul Hye Khan, John D Imig
Pageof 20

Showing results (21-30 of 193) with videos related to

Sort By:
Pageof 20
American Journal of Physiology. Renal Physiology|March 11, 2016
Renal blood flow autoregulation: what are the contributions for nitric oxide or superoxide to modulate the myogenic response?John D Imig
Frontiers in Physiology|August 29, 2022
Frontiers in metabolic physiology grand challengesJohn D Imig
Cardiovascular Drug Reviews|September 12, 2006
Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitorsJohn D Imig
Clinical Science (London, England : 1979)|March 29, 2022
SARS-CoV-2 spike protein causes cardiovascular disease independent of viral infectionJohn D Imig
Kidney360|December 18, 2025
NF Erythroid 2-Related Factor 2 Peroxisome Proliferator-Activated Receptor-γ Crosstalk: Reprogramming Monocytic Myeloid-Derived Suppressor Cells in Kidney DiseaseJohn D Imig
Frontiers in Pharmacology|October 19, 2020
Editorial: Clinical Paths for Soluble Epoxide Hydrolase InhibitorsJohn D Imig, Christophe Morisseau
Physiological Reports|October 26, 2013
Afferent Arteriolar Responses to β,γ-methylene ATP and 20-HETE are not Blocked by ENaC InhibitionTasuku Nagasawa, John D Imig
Comprehensive Physiology|May 31, 2013
Immune and inflammatory role in renal diseaseJohn D Imig, Michael J Ryan
American Journal of Physiology. Renal Physiology|September 11, 2015
Reply to "Letter to the editor: 'Concern regarding quantification of urinary nephrin by commercially available ELISA'"Jennifer C Sullivan, John D Imig
American Journal of Hypertension|March 19, 2011
Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndromeAbdul Hye Khan, John D Imig
Pageof 20